Risa, a regulator of insulin sensitivity and autophagy, was found to improve the autophagy levels in renal podocytes through inhibition via the Sirt1/GSK3β (glycogen synthase kinase-3β) pathway, thereby promoting the progression of DKD [88]. Here, SIRT1 is linked to diabetic kidney disease.